BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23200691)

  • 1. PROKR2 mutations in autosomal recessive Kallmann syndrome.
    Tommiska J; Toppari J; Vaaralahti K; Känsäkoski J; Laitinen EM; Noisa P; Kinnala A; Niinikoski H; Raivio T
    Fertil Steril; 2013 Mar; 99(3):815-8. PubMed ID: 23200691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome.
    Abreu AP; Trarbach EB; de Castro M; Frade Costa EM; Versiani B; Matias Baptista MT; Garmes HM; Mendonca BB; Latronico AC
    J Clin Endocrinol Metab; 2008 Oct; 93(10):4113-8. PubMed ID: 18682503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation analyses in pedigrees and sporadic cases of ethnic Han Chinese Kallmann syndrome patients.
    Gu WJ; Zhang Q; Wang YQ; Yang GQ; Hong TP; Zhu DL; Yang JK; Ning G; Jin N; Chen K; Zang L; Wang AP; Du J; Wang XL; Yang LJ; Ba JM; Lv ZH; Dou JT; Mu YM
    Exp Biol Med (Maywood); 2015 Nov; 240(11):1480-9. PubMed ID: 26031747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PROKR2 missense mutations associated with Kallmann syndrome impair receptor signalling activity.
    Monnier C; Dodé C; Fabre L; Teixeira L; Labesse G; Pin JP; Hardelin JP; Rondard P
    Hum Mol Genet; 2009 Jan; 18(1):75-81. PubMed ID: 18826963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The complex genetics of Kallmann syndrome: KAL1, FGFR1, FGF8, PROKR2, PROK2, et al.
    Hardelin JP; Dodé C
    Sex Dev; 2008; 2(4-5):181-93. PubMed ID: 18987492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kallmann syndrome caused by mutations in the PROK2 and PROKR2 genes: pathophysiology and genotype-phenotype correlations.
    Sarfati J; Dodé C; Young J
    Front Horm Res; 2010; 39():121-132. PubMed ID: 20389090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1.
    Canto P; Munguía P; Söderlund D; Castro JJ; Méndez JP
    J Androl; 2009; 30(1):41-5. PubMed ID: 18723471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kallmann syndrome with a Tyr113His PROKR2 mutation.
    Ha JH; Lee S; Kim Y; Moon JI; Seo J; Jang JH; Cho EH; Kim JM; Rhee BD; Ko KS; Yoo SJ; Won JC
    Medicine (Baltimore); 2017 Sep; 96(35):e7974. PubMed ID: 28858133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2.
    Dodé C; Teixeira L; Levilliers J; Fouveaut C; Bouchard P; Kottler ML; Lespinasse J; Lienhardt-Roussie A; Mathieu M; Moerman A; Morgan G; Murat A; Toublanc JE; Wolczynski S; Delpech M; Petit C; Young J; Hardelin JP
    PLoS Genet; 2006 Oct; 2(10):e175. PubMed ID: 17054399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic overlap in Kallmann syndrome, combined pituitary hormone deficiency, and septo-optic dysplasia.
    Raivio T; Avbelj M; McCabe MJ; Romero CJ; Dwyer AA; Tommiska J; Sykiotis GP; Gregory LC; Diaczok D; Tziaferi V; Elting MW; Padidela R; Plummer L; Martin C; Feng B; Zhang C; Zhou QY; Chen H; Mohammadi M; Quinton R; Sidis Y; Radovick S; Dattani MT; Pitteloud N
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E694-9. PubMed ID: 22319038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variations in PROKR2, but not PROK2, are associated with hypopituitarism and septo-optic dysplasia.
    McCabe MJ; Gaston-Massuet C; Gregory LC; Alatzoglou KS; Tziaferi V; Sbai O; Rondard P; Masumoto KH; Nagano M; Shigeyoshi Y; Pfeifer M; Hulse T; Buchanan CR; Pitteloud N; Martinez-Barbera JP; Dattani MT
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E547-57. PubMed ID: 23386640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biallelic mutations in the prokineticin-2 gene in two sporadic cases of Kallmann syndrome.
    Leroy C; Fouveaut C; Leclercq S; Jacquemont S; Boullay HD; Lespinasse J; Delpech M; Dupont JM; Hardelin JP; Dodé C
    Eur J Hum Genet; 2008 Jul; 16(7):865-8. PubMed ID: 18285834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum.
    Cole LW; Sidis Y; Zhang C; Quinton R; Plummer L; Pignatelli D; Hughes VA; Dwyer AA; Raivio T; Hayes FJ; Seminara SB; Huot C; Alos N; Speiser P; Takeshita A; Van Vliet G; Pearce S; Crowley WF; Zhou QY; Pitteloud N
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3551-9. PubMed ID: 18559922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel FGFR1 mutations in Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: evidence for the involvement of an alternatively spliced isoform.
    Gonçalves C; Bastos M; Pignatelli D; Borges T; Aragüés JM; Fonseca F; Pereira BD; Socorro S; Lemos MC
    Fertil Steril; 2015 Nov; 104(5):1261-7.e1. PubMed ID: 26277103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PROKR2 and PROK2 mutations cause isolated congenital anosmia without gonadotropic deficiency.
    Moya-Plana A; Villanueva C; Laccourreye O; Bonfils P; de Roux N
    Eur J Endocrinol; 2013 Jan; 168(1):31-7. PubMed ID: 23082007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Greater prevalence of PROKR2 mutations in Kallmann syndrome patients from the Maghreb than in European patients.
    Sarfati J; Fouveaut C; Leroy C; Jeanpierre M; Hardelin JP; Dodé C
    Eur J Endocrinol; 2013 Dec; 169(6):805-9. PubMed ID: 24031091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes.
    Sarfati J; Guiochon-Mantel A; Rondard P; Arnulf I; Garcia-Piñero A; Wolczynski S; Brailly-Tabard S; Bidet M; Ramos-Arroyo M; Mathieu M; Lienhardt-Roussie A; Morgan G; Turki Z; Bremont C; Lespinasse J; Du Boullay H; Chabbert-Buffet N; Jacquemont S; Reach G; De Talence N; Tonella P; Conrad B; Despert F; Delobel B; Brue T; Bouvattier C; Cabrol S; Pugeat M; Murat A; Bouchard P; Hardelin JP; Dodé C; Young J
    J Clin Endocrinol Metab; 2010 Feb; 95(2):659-69. PubMed ID: 20022991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prokr2-deficient mice display vascular dysmorphology of the fetal testes: potential implications for Kallmann syndrome aetiology.
    Svingen T; McClelland KS; Masumoto K; Sujino M; Nagano M; Shigeyoshi Y; Koopman P
    Sex Dev; 2011; 5(6):294-303. PubMed ID: 22223120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional mutation in
    Ichioka K; Yoshikawa T; Kimura H; Saito R
    BMJ Case Rep; 2024 Jan; 17(1):. PubMed ID: 38272512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homozygous mutation in the prokineticin-receptor2 gene (Val274Asp) presenting as reversible Kallmann syndrome and persistent oligozoospermia: case report.
    Sinisi AA; Asci R; Bellastella G; Maione L; Esposito D; Elefante A; De Bellis A; Bellastella A; Iolascon A
    Hum Reprod; 2008 Oct; 23(10):2380-4. PubMed ID: 18596028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.